These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 29017215
1. [Pulmonary Embolism Despite Rivaroxaban in an Obese Patient]. Schuh T, Stöllberger C. Dtsch Med Wochenschr; 2017 Oct; 142(20):1548-1551. PubMed ID: 29017215 [Abstract] [Full Text] [Related]
2. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. Ageno W, Mantovani LG, Haas S, Kreutz R, Monje D, Schneider J, van Eickels M, Gebel M, Zell E, Turpie AG. Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643 [Abstract] [Full Text] [Related]
3. Pulmonary embolism four days after interruption of therapy with rivaroxaban. Göndör G, Stöllberger C. Hamostaseologie; 2017 Oct 26; 37(4):302-306. PubMed ID: 28853765 [Abstract] [Full Text] [Related]
4. Management, control, and decision making in unexpected recurrent venous thromboembolism in COVID-19: a case report. Zolfaghari Emameh R, Heshmatnia J. J Med Case Rep; 2023 Mar 19; 17(1):101. PubMed ID: 36934279 [Abstract] [Full Text] [Related]
5. Multidisciplinary approach to the management of patients with pulmonary embolism and deep vein thrombosis: a consensus on diagnosis, traditional therapy and therapy with rivaroxaban. Imberti D, Becattini C, Bernardi E, Camporese G, Cuccia C, Dentali F, Paretti D. Intern Emerg Med; 2018 Oct 19; 13(7):1037-1049. PubMed ID: 29520700 [Abstract] [Full Text] [Related]
6. Recurrent venous thromboembolism after discontinuation of rivaroxaban therapy in a patient with antiphospholipid syndrome. Yagi S, Nishiyama S, Abe T, Sata M. BMJ Case Rep; 2019 Jan 10; 12(1):. PubMed ID: 30635311 [Abstract] [Full Text] [Related]
14. Management of pulmonary embolism after recent intracranial hemorrhage: A case report. Lee WC, Fang HY. Medicine (Baltimore); 2018 Apr 10; 97(15):e0479. PubMed ID: 29642222 [Abstract] [Full Text] [Related]
16. Perioperative venous thromboembolic disease and the emerging role of the novel oral anticoagulants: an analysis of the implications for perioperative management. Mookadam M, Shamoun FE, Ramakrishna H, Obeid H, Rife RL, Mookadam F. Ann Card Anaesth; 2015 Apr 10; 18(4):517-27. PubMed ID: 26440238 [Abstract] [Full Text] [Related]
17. Comparison of rivaroxaban mono-therapy and standard-therapy adjusted by CYP2C9 and VKORC1 genotypes in symptomatic pulmonary embolism. Duan L, Zhang N, Yan H, Guo Y, Hong C, Yang X, Su X, Chen R, Zhou Y, Zhong N, Liu C. Clin Chim Acta; 2016 Aug 01; 459():25-29. PubMed ID: 27155586 [Abstract] [Full Text] [Related]